Planet 13 Holdings (PLNH) Current Deferred Revenue (2021 - 2025)
Planet 13 Holdings (PLNH) posted quarterly Current Deferred Revenue of $226627.0 for Q4 2025, down 90.72% year-over-year from $2.4 million in Q4 2024, and down 90.72% quarter-over-quarter from $2.4 million in Q4 2024.
Planet 13 Holdings (PLNH) Current Deferred Revenue (2021 - 2025) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Current Deferred Revenue for 5 consecutive years, with $226627.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Deferred Revenue fell 90.72% year-over-year to $226627.0; the TTM figure through Dec 2025 stood at $226627.0 (down 90.72% YoY), while the FY2025 annual figure was $226627.0, down 90.72% from the prior year.
- Current Deferred Revenue eased to $226627.0 in Q4 2025 per PLNH's latest filing, from $2.4 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $2.4 million in Q4 2024 and bottomed at $226627.0 in Q4 2025.
- Historically, Current Deferred Revenue has averaged $1.1 million across 5 years, with a median of $1.0 million in 2022.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue soared 95.54% — and 2025, when it slumped 90.72%.
- Planet 13 Holdings' Current Deferred Revenue stood at $759060.0 in 2021, then surged by 38.04% to $1.0 million in 2022, then grew by 19.17% to $1.2 million in 2023, then jumped by 95.54% to $2.4 million in 2024, then plunged by 90.72% to $226627.0 in 2025.
- Business Quant data shows PLNH's Current Deferred Revenue at $226627.0 in Q4 2025, $2.4 million in Q4 2024, and $1.2 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Planet 13 Holdings | 52.64 Mn | 36.16 Mn | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 226,627.00 |
| Dec 31, 2024 | 2.44 Mn |
| Dec 31, 2023 | 1.25 Mn |
| Dec 31, 2022 | 1.05 Mn |
| Dec 31, 2021 | 759,060.00 |